Goodwood Festival of Speed targets Beach for auto classic

Goodwood Festival of Speed targets Beach for auto classic
Published by Monica Correa on November 15, 2022
  • www.miamitodayepaper.com

Ad

Goodwood Festival of Speed targets Beach for auto classic

Pending a town contract, the Goodwood Competition of Speed is coming to Miami Beach, promising to provide luminaries of the earth of racing, vehicle collectors and exhibitors, with a focus on the foreseeable future of transportation and the conclude of fossil fuels use.

Founded by the existing Duke of Richmond in his Goodwood Property in Chichester, West Sussex, South of England, 30 several years ago, the Goodwood Pageant of Speed is the greatest celebration of motorsports, auto style and vehicle society in the world, explained Tim Bulley, intercontinental director of The Goodwood Team. “This is the finest assortment of autos in the globe,” he reported. “Appearance is by stringent invitation only. The motor vehicle receives the invite, not the operator.”

The function would encompass pieces of Ocean Generate and Lummus Park, from Fifth to 15th streets, together with Collins Park, due to the fact which is where by the Concourse d’Elegance – a environment-famous auction of historic automobiles – would be, stated Marcia Monserrat, Miami Seashore main of staff. “They anticipate that just their associates and their sellers will acquire up [most of] the resort rooms on Ocean Drive,” she said. “They genuinely can modify what our March will glimpse like. It definitely will be the viewers that we’re on the lookout for, in a extremely family members-helpful occasion.”

The festival is prepared to consider spot for the duration of the 3rd weekend of March 2024. The heaviest create-out is to be on the sand, wherever the team would established up the Future Lab, an innovation pavilion with “dynamic, interactive know-how to encourage everybody from sector, from enthusiasts to the subsequent era of experts, inventors and explorers,” in accordance to the Goodwood website. The tech pavilion would emphasize sustainable improvement, electric powered vehicles, motors, and robotics.

The festival is to appear as part of the focused programming that the Town of Miami Seaside began producing starting in 2021, termed “Miami Seashore Reside!”
Future year’s programming for March will start off with the ITF Beach Tennis Planet Cup Qualifier, March 1-4 Miami Beach front Brazil compared to Colombia Tennis Problem on March 4 Miami Seaside US versus Brazil Seashore Soccer Obstacle, from Sixth to Ninth streets at the beachfront March 8-12, King of the Court Crown Collection March 10-12, Big League Baseball “World Baseball Common Fanfest” Lummus Park, Sixth to Ninth streets and Ocean Push March 17-19, Kiwanis of Very little Havana “Art on the Generate: a Carnival Miami Experience” in Lummus Park, Sixth to 13th streets and Ocean Push March 24-26, Miami Beach Exercise Festival run by M Athlete at Sixth and Ninth streets at the beachfront.

For the adhering to year, the metropolis partnered with the Larger Miami Convention & Guests Bureau (GMCVB) “to uncover out what large-scale celebration could we entice to come to Miami Beach, and precisely to South Seaside,” said Ms. Monserrat, “and the GMCVB and Miami-Dade County connected us with Goodwood.”

With around 30 automobile manufacturers exhibiting, “it was an celebration that we preferred to bring that would emphasize the society of the potential of transportation, and it is not just vehicles, but also boats and nearly anything likely into the future that is not fossil fuels-dependent,” said Jose Sotolongo, director of sports and amusement tourism at the GMCVB.

“The actuality that they’re likely to be included with the educational part of it, with our kids in the foreseeable future is also really fascinating for us. Mainly because of the volume of lodge area nights [generated], the work alternatives for our regional people, we are absolutely powering it.”

In the course of the 2022 Pageant of Pace function, past June at the Goodwood Home, “we had Edison’s first electric car or truck of 1908,” explained Mr. Bulley. Other legendary vehicles integrated James Bond common Aston Martin DBS Superleggera, Jaguar 3.5 Litre Roadster, Mercedes SLS AMG Coupe, Power India F1 Motor vehicle, and the Ferrari Dini GTS. Celebrity appearances involved ex-soccer player David Beckham, Television chef Gordon Ramsay, and NFL gamers Danielle Hunter and K.J. Osborn.

This year’s event supported the Race Towards Dementia charity, launched by Method 1 Globe Winner Sir Jackie Steward. “Each 12 months, we rejoice a concept, an anniversary or a moment in time, which tends to make no festival very same as the other,” mentioned Mr. Bulley.

Goodwood Group, he claimed, has worked with sporting activities consultants and has calculated the economic affect to reach 121,500 resort place beds, worth about $17.8 million for each 12 months, $27.6 million in non-lodging, $6 million in non-local sponsor activation and $12 million in media income. Organizers count on about 102,000 attendees and 69,860 spectators, “in addition to the $45 million that we will be spending to set the celebration in the regional financial state.”

If the agreement is signed, the town is to concur to cover protection providers, facilities, and other metropolis things, these kinds of as waste management and a cleanse zone, mentioned Mr. Bulley. Goodwood Team would also involve a extended-time period determination from the town of a 5-yr furthermore 5-12 months arrangement.

“We ambition to choose the event about the world,” he added. “We have, to day, explored several possibilities in the US, but the metropolis of Miami Beach front ticks all the boxes. It is a entire world-foremost glamorous spot that our owners’ shoppers and clients will want to journey to. It is in close proximity to South The us, and extremely importantly, to Florida technological innovation.”

Why Pregnant People Were Left Behind While Vaccines Moved at ‘Warp Speed’ to Help the Masses

Why Pregnant People Were Left Behind While Vaccines Moved at ‘Warp Speed’ to Help the Masses

Kia Slade was seven months pregnant, unvaccinated, and fighting for breath, her oxygen levels plummeting, when her son came into the world last May.

A severe case of covid pneumonia had left Slade delirious. When the intensive care team tried to place an oxygen mask on her face, she snatched it away, she recalled. Her baby’s heart rate began to drop.

Slade’s doctor performed an emergency cesarean section at her bedside in the intensive care unit, delivering baby Tristan 10 weeks early. He weighed just 2 pounds, 14 ounces, about half the size of small full-term baby.

But Slade wouldn’t meet him until July. She was on a ventilator in a medically induced coma for eight weeks, and she developed a serious infection and blood clot while unconscious. It was only after a perilous 2½ months in the hospital, during which her heart stopped twice, that Slade was vaccinated against covid-19.

“I wish I had gotten the vaccine earlier,” said Slade, 42, who remains too sick to return to work as a special education teacher in Baltimore. Doctors “kept pushing me to get vaccinated, but there just wasn’t enough information out there for me to do it.”

A year ago, there was little to no vaccine safety data for pregnant people like Slade, because they had been excluded from clinical trials run by Pfizer, Moderna, and other vaccine makers.

Lacking data, health experts were unsure and divided about how to advise expectant parents. Although U.S. health officials permitted pregnant people to be vaccinated, the World Health Organization in January 2021 actually discouraged them from doing so; it later reversed that recommendation.

The uncertainty led many women to delay vaccination, and only about two-thirds of the pregnant people who have been tracked by the Centers for Disease Control and Prevention were fully vaccinated as of Feb. 5, leaving many expectant moms at a high risk of infection and life-threatening complications.

More than 29,000 pregnant people have been hospitalized with covid and 274 have died, according to the CDC.

“There were surely women who were hospitalized because there wasn’t information available to them,” said Dr. Paul Offit, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.

Vaccine developers say that pregnant people — who have special health needs and risks — were excluded from clinical trials to protect them from potential side effects of novel technologies, including the Pfizer and Moderna mRNA vaccines and formulations made with cold viruses, such as the Johnson & Johnson vaccine.

But a KHN analysis also shows that pregnant people were left behind because including them in vaccine studies would have complicated and potentially delayed the delivery of covid vaccines to the broader population.

A growing number of women’s health researchers and advocates say that excluding pregnant people — and the months-long delay in recommending that they be immunized — helped fuel widespread vaccine hesitancy in this vulnerable group.

“Women and their unborn fetuses are dying of covid infection,” said Dr. Jane Van Dis, an OB-GYN at the University of Rochester Medical Center who has treated many patients like Slade. “Our failure as a society to vaccinate women in pregnancy will be remembered by the children and families who lost their mothers to this disease.”

New Technology, Uncertain Risks

At the time covid vaccines were being developed, scientists had very little experience using mRNA vaccines in pregnant women, said Dr. Jacqueline Miller, a senior vice president involved in vaccine research at Moderna.

“When you study anything in pregnant women, you have two patients, the mom and the unborn child,” Miller said. “Until we had more safety data on the platform, it wasn’t something we wanted to undertake.”

But Offit notes that vaccines have a strong record of safety in pregnancy and sees no reason to have excluded pregnant people. None of the vaccines currently in use — including the chickenpox and rubella vaccines, which contain live viruses — have been shown to harm fetuses, he said. Doctors routinely recommend that pregnant people receive pertussis and flu vaccinations.

Offit, the co-inventor of a rotavirus vaccine, said that some concerns about vaccines stem from commercial, not medical, interests. Drugmakers don’t want to risk that their product will be blamed for any problems occurring in pregnant people, even if coincidental, he said.

“These companies don’t want bad news,” Offit said.

In the United States, health officials typically would have told expectant mothers not to take a vaccine that was untested during pregnancy, said Offit, a member of a committee that advises the FDA on vaccines.

Due to the urgency of the pandemic, health agencies instead permitted pregnant people to make up their own minds about vaccines without recommending them.

Women’s medical associations were also hampered by the lack of data. Neither the American College of Obstetricians and Gynecologists nor the Society for Maternal-Fetal Medicine actively encouraged pregnant people to be vaccinated until July 30, after the first real-world vaccine studies had been published. The CDC followed suit in August.

“If we had had this data in the beginning, we would have been able to vaccinate more women,” said Dr. Kelli Burroughs, the department chairman of obstetrics and gynecology at Memorial Hermann Sugar Land Hospital near Houston.

Yet anti-vaccine groups wasted no time in scaring pregnant people, flooding social media with misinformation about impaired fertility and harm to the fetus.

In the first few months after the covid vaccines were approved, some doctors were ambivalent about recommending them, and some still advise pregnant patients against vaccination.

An estimated 67{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of pregnant people today are fully vaccinated, compared with about 89{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of people 65 and older, another high-risk group, and 65{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of Americans overall. Vaccination rates are lower among minorities, with 65{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of expectant Hispanic mothers and 53{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of pregnant African Americans fully vaccinated, according to the CDC.

Vaccination is especially important during pregnancy, due to increased risks of hospitalization, ICU admission and mechanical ventilation, Burroughs said. A study released in February from the National Institutes of Health found that pregnant people with a moderate to severe covid infection also were more likely to have a C-section, deliver preterm, or develop a postpartum hemorrhage.

Black moms such as Slade were already at higher risk of maternal and infant mortality before the pandemic, due to higher underlying risks, unequal access to health care, and other factors. Covid has only magnified those risks, said Burroughs, who has persuaded reluctant patients by revealing that she had a healthy pregnancy and child after being vaccinated.

Slade said she has never opposed vaccines and had no hesitation about receiving other vaccines while pregnant. But she said she “just wasn’t comfortable” with covid shots.

“If there had been data out there saying the covid shot was safe, and that nothing would happen to my baby and there was no risk of birth defects, I would have taken it,” said Slade, who has had Type 2 diabetes for 12 years.

Working at Warp Speed

Government scientists at the NIH were concerned about the risk of covid to pregnant people from the very beginning and knew that expectant moms needed vaccines as much or more than anyone else, said Dr. Larry Corey, a leader of the COVID-19 Prevention Network, which coordinated covid vaccine trials for the federal government.

But including pregnant volunteers in the larger vaccine trials could have led to interruptions and delays, Corey said. Researchers would have had to enroll thousands of pregnant volunteers to achieve statistically robust results that weren’t due to chance, he said.

Pregnancy can bring on a wide range of complications: gestational diabetes, hypertension, anemia, bleeding, blood clots, or problems with the placenta, for example. Up to 20{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} of people who know they’re pregnant miscarry. Because researchers would have been obliged to investigate any medical problem to make sure it wasn’t caused by one of the covid vaccines, including pregnant people might have meant having to hit pause on those trials, Corey said.

With death tolls from the pandemic mounting, “we had a mission to do this as quickly and as thoroughly as possible,” Corey said. Making covid vaccines available within a year “saved hundreds of thousands of lives.”

The first data on covid vaccine safety in pregnancy was published in April, when the CDC released an analysis of nearly 36,000 vaccinated pregnant people who had enrolled in a registry called V-safe, which allows users to log the dates of their vaccinations and any subsequent symptoms.

Later research showed that covid vaccines weren’t associated with increased risk of miscarriage or premature delivery.

Dr. Brenna Hughes, a maternal-fetal medicine specialist and member of the American College of Obstetricians and Gynecologists’ covid expert group, agrees that adding pregnant people to large-scale covid vaccine and drug trials may have been impractical. But researchers could have launched parallel trials of pregnant women, once early studies showed the vaccines were safe in humans, she said.

“Would it have been hard? Everything with covid is hard,” Hughes said. “But it would have been feasible.”

The FDA requires that researchers perform additional animal studies — called developmental and reproductive toxicity studies — before testing vaccines in pregnant people. Although these studies are essential, they take five to six months, and weren’t completed until late 2020, around the time the first covid vaccines were authorized for adults, said Dr. Emily Erbelding, director of microbiology and infectious diseases at the National Institute of Allergy and Infectious Diseases, part of NIH.

Pregnancy studies “were an afterthought,” said Dr. Irina Burd, director of Johns Hopkins’ Integrated Research Center for Fetal Medicine and a professor of gynecology and obstetrics. “They should have been done sooner.”

The NIH is conducting a study of pregnant and postpartum people who decided on their own to be vaccinated, Erbelding said. The study is due to be completed by July 2023.

Janssen and Moderna are also conducting studies in pregnant people, both due to be completed in 2024.

Pfizer scientists encountered problems when they initiated a clinical trial, which would have randomly assigned pregnant people to receive either a vaccine or placebo. Once vaccines were widely available, many patients weren’t willing to take a chance on being unvaccinated until after delivery.

Pfizer has stopped recruiting patients and has not said whether it will publicly report any data from the trial.

Hughes said vaccine developers need to include pregnant people from the very beginning.

“There is this notion of protecting pregnant people from research,” Hughes said. “But we should be protecting patients through research, not from research.”

Recovering Physically and Emotionally

Slade still regrets being deprived of time with her children while she fought the disease.

Being on a ventilator kept her from spending those early weeks with her newborn, or from seeing her 9-year-old daughter, Zoe.

Even when Slade was finally able to see her son, she wasn’t able to tell him she loved him or sing a lullaby, or even talk at all, due to a breathing tube in her throat.

Today, Slade is a strong advocate of covid vaccinations, urging her friends and family to get their shots to avoid suffering the way she has.

Slade had to relearn to walk after being bedridden for weeks. Her many weeks on a ventilator may have contributed to her stomach paralysis, which often causes intense pain, nausea and even vomiting when she eats or drinks. Slade weighs 50 pounds less today than before she became pregnant and has resorted to going to the emergency room when the pain is unbearable. “Most days, I’m just miserable,” Slade said.

Her family suffered, as well. Like many babies born prematurely, Tristan, now nearly 9 months old and crawling, receives physical therapy to strengthen his muscles. At 15 pounds, Tristan is largely healthy, although his doctor said he has symptoms of asthma.

Slade said she would like to attend family counseling with Zoe, who rarely complains and tends to keep her feelings to herself. Slade knows her illness must have been terrifying for her little girl.

“The other day she was talking to me,” Slade said, “and she said, ‘You know, I almost had to bury you.’”

KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.

USE OUR CONTENT

This story can be republished for free (details).

The effect of wind speed

Leaves blowing in the wind as the sun setsShare on Pinterest
Wind speed may play a role in outdoor transmission rates. crisserbug/Getty Images
  • A recent study investigated the role of wind speed in SARS-CoV-2 transmission in outdoor spaces.
  • Reduced wind speed had associations with transmission rates during warmer spells.
  • However, above a certain temperature, wind speed made little difference to transmission rates, possibly because people were more likely to socialize indoors.

New research, which appears in BMC Infectious Diseases, suggests certain weather conditions may pose less risk of transmission than others.

To investigate, researchers analyzed 96,057 cases of SARS-CoV-2 infection in Suffolk County, NY, that occurred between March and December in 2020.

Combining data from the Suffolk County Department of Health with daily weather reports by the National Oceanic and Atmospheric Administration, the authors “[h]ypothesized that slower outdoor wind speed is associated with increased risk of transmission when individuals socialize outside.”

Higher outdoor wind speeds on warmer days were associated with up to a 45{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} lower risk of SARS-CoV-2 transmission in social gatherings.

Wind speeds of less than 5.5 miles per hour (mph) seemed to be associated with greater transmission than faster speeds. As SARS-CoV-2 is airborne, scientists believe that higher wind speeds disperse viral particles and reduce infection risk.

Since cooler outdoor temperatures are less conducive to social gatherings, they may have indirectly increased infection rates — people may have been more inclined to move inside.

Evidence now shows that transmission rates are highest indoors, which means airflow and quality will also help mitigate the risk of infection.

Infection rates were highest in March through May but significantly dropped when officials implemented stay-at-home orders.

New infections in Suffolk County were very low throughout the summer months of 2020 but started to rise again after October.

While low wind speeds under 5 mph may reduce the protective effect of warmer temperatures, the study authors noted that this does not prove that higher wind speeds protected any individuals in outdoor social gatherings from infection.

Medical News Today spoke with Sean Clouston, Ph.D., associate professor in the Department of Family, Population, and Preventive Medicine at the Renaissance School of Medicine at Stony Brook University, NY.

He pointed out that while temperature and wind speed appear to play a role, they are not the only factors, and protection against COVID-19 involves personal responsibility. This includes mask wearing and vaccinations.

“It is generally safer to be outside than inside,” he told MNT. “The danger with outside gatherings, of course, is that if the weather turns, people often shelter indoors. I think the science on mask wearing is improving a lot, and it looks like mask usage drastically cuts transmission even indoors.”

“The problem is that when people relax gathering limits,” he continued, “they often do not provide guidelines and many people do not adhere to them. In general, I would agree that it’s okay to have gatherings outdoors where masks were required for any indoor spaces, including bathrooms.”

“But mask wearing has to be done appropriately, and vaccinations should be required. Also, any larger gatherings should probably not include dining unless adequate measures are taken to ensure that it’s done safely.”

Study co-author Jaymie R. Meliker, Ph.D., a professor in the Program in Public Health and Faculty Member in Consortium for Inter-Disciplinary Environmental Research at Stony Brook University, echoed his colleague.

He reiterated that transmission is multifactorial and that proactive efforts are necessary to curtail the spread of the virus. He told MNT:

“We know that many cases of COVID-19 transmission remain unexplained. The analysis presented in this article suggests that some of those cases may be transmitted in outdoor settings when wind speed is low — in other words, when air is more stagnant.”

“Transmission is higher outdoors when wind speed is low and people are spending time outdoors,” Prof. Meliker continued, “When temperatures get too cold or too hot, people are spending less time outdoors, and we no longer see an association between low wind speed and COVID-19 incidence.”

“These data are consistent with current guidance for reducing transmission: adopt a multifaceted approach that includes vaccinations, mask wearing, and increased air turnover (indoors or outdoors),” he concluded.

Antibody levels might help speed up approval

Share on Pinterest
New research suggests that antibody levels generated by vaccines could be an accurate way of measuring effectiveness. Image credit: Michaela Handrek-Rehle/Bloomberg via Getty Images.
  • Health authorities only approve the use of COVID-19 vaccines that have gone through rigorous clinical trials.
  • Scientists assess whether a vaccine is effective by checking whether participants in a trial develop the infection after having the vaccine.
  • In the present study, researchers find that a person’s antibody response could serve a correlate of effectiveness, instead of whether people develop the infection.
  • Using this proposed measure could speed up the regulatory approval of future vaccines.

In a new study, scientists have found that antibody levels can help indicate the effectiveness of the Moderna COVID-19 vaccine.

The research, published in the journal Science, may be the first step toward speeding up the regulatory approval process for future vaccines.

In theory, scientists could use antibody levels to identify vaccine effectiveness, rather than clinical trials to investigate how many vaccinated people develop severe COVID-19.

The speed with which scientists have developed vaccines for SARS-CoV-2, the virus that causes COVID-19, is unprecedented.

Previously, vaccine development typically took 10–15 years. By contrast, the Pfizer-BioNTech vaccine received emergency regulatory approval from the Food and Drug Administration (FDA) on December 11, 2020, less than a year after scientists first identified the virus.

However, researchers are still eager to reduce the time it takes to develop future vaccines.

Scientists may do this by identifying biomarkers that can stand in for the results of clinical trials. If these biomarkers can accurately predict how effective the vaccine is, it may obviate the need to see how many people develop the infection in a clinical trial.

Speaking to Medical News Today, Prof. Florian Kern, chair in immunology at the Brighton and Sussex Medical School, in the United Kingdom, said, “If it were possible to define a laboratory endpoint — in this case an immunological marker — that can tell us if someone is protected or not, it would be easier to measure the protective effect of a vaccine quickly and compare this effect to that of other vaccines.” Prof. Kern was not involved in the new study.

In the study, the researchers wanted to see whether antibodies produced in response to the Moderna COVID-19 vaccine could accurately predict whether the vaccine was effective.

They did this by analyzing data from the phase 3 trials of the vaccine. The researchers were looking at the level of binding and neutralizing antibodies produced and at certain properties of these antibodies.

The team focused on these biomarkers assessed at the point of the second vaccination and 4 weeks afterward.

The researchers found a clear link between higher levels of antibodies and greater protection against symptomatic COVID-19 .

Participants with antibody levels in the top 10{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} had a 10 times lower risk of symptomatic COVID-19 compared with participants who had undetectable or negative antibody values. This was the case no matter which antibody biomarker the researchers focused on.

MNT spoke with Dr. Peter Gilbert, a professor in the Vaccine and Infectious Disease Division of Fred Hutchinson Cancer Research Center, in Seattle, and the corresponding author of the study.

Summarizing the findings, Dr. Gilbert explained, “Four separate tests used to measure antibody levels in the blood showed that the higher a vaccine recipient’s antibody response, the less likely [they were] to experience symptomatic COVID-19.”

“The same measurements also indicated that higher antibody responses correlated with higher estimated vaccine efficacy against symptomatic COVID-19.”

“The findings are based on data from the phase 3 COVE trial, which enrolled more than 30,000 adult volunteers and established 94.1{cfdf3f5372635aeb15fd3e2aecc7cb5d7150695e02bd72e0a44f1581164ad809} estimated vaccine efficacy against COVID-19 for the mRNA-1273 vaccine,” Dr. Gilbert added.

He also noted that the findings may help accelerate the approval process for future vaccines.

“Correlates of protection are surrogate markers of efficacy that can be used to reliably predict whether a vaccine will be protective, which can accelerate regulatory authorization and approval of vaccine candidates.”

“Rather than conducting large-scale clinical trials to establish vaccine efficacy, which can require tens of thousands of volunteers and can take months to years to complete, data collected from blood samples from smaller cohorts of vaccinated individuals can be evaluated using a particular test that would indicate whether a vaccine is likely to have clinical benefit in that population.”

– Dr. Peter Gilbert, corresponding author of the new study

The study authors caution that their investigation had a short follow-up period and included a relatively small number of COVID-19 cases. Also, the group did not consider the effects of booster vaccines or different variants of the virus, as these had not emerged when the trial was conducted. The trial had sampled a large and ethnically diverse number of participants for its immunogenicity measurements.

“While it may seem like an obvious finding that that more antibodies equates to higher levels of protection against COVID-19, this detailed analysis advances evidence toward establishing a correlate of protection that could be used to accelerate regulatory processes for variant-specific formulations of mRNA COVID-19 vaccines, as well as authorization of prototype mRNA COVID-19 vaccines in children,” said Dr. Gilbert.

For live updates on the latest developments regarding the novel coronavirus and COVID-19, click here.